Latest news with #FIP
Yahoo
3 days ago
- Business
- Yahoo
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J., June 05, 2025--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. "FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too," said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. "For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance." "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients," said Nicole Jacque, co-founder of FIP Global Cats. "Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP." Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About WedgewoodWedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit View source version on Contacts Jennifer Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 days ago
- Business
- Business Wire
Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
SWEDESBORO, N.J.--(BUSINESS WIRE)--Wedgewood Pharmacy today announced the availability of a GS-441524 formula, a compounded oral antiviral formulation now part of its feline infectious peritonitis (FIP) treatment capabilities. With this addition, veterinarians can now prescribe both GS-441524 and Molnupiravir for their patients, two of the most requested compounded antivirals for FIP, through a single trusted source backed by pharmacist support and FDA-registered ingredient sourcing. "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment." Share GS-441524 can be compounded as a 50mg/ml flavored oral oil suspension in multiple sizes, to improve compliance and ease of administration. The addition complements Wedgewood's Molnupiravir formulations, giving veterinarians access to two antivirals with distinct mechanisms of action. 'FIP is one of the toughest diagnoses we face, not just clinically, but emotionally too,' said Dr. Rae Hutchins, Chief Veterinary Officer at Wedgewood. 'For a long time, vets had to deal with inconsistent access and quality when it came to GS-441524. Now, by offering both GS-441524 and Molnupiravir from one trusted, pharmacist-supported source, we're making it easier for veterinarians to focus on what matters most, giving their patients the best possible chance.' "Having access to both GS-441524 and Molnupiravir compounded formulations through Wedgewood not only widens access to affordable FIP treatment across the US, but it also gives veterinarians the ability to easily choose and adapt treatment to best suit the needs of their patients and clients,' said Nicole Jacque, co-founder of FIP Global Cats. 'Having pharmacists who understand the urgency and complexity of these cases partnering with veterinarians is key to ensuring the best treatment outcomes for cats with FIP.' Until recently, many veterinarians relied on fragmented or unregulated sources for GS-441524, making it difficult to ensure consistency and continuity of care. The introduction of this option through Wedgewood reflects a direct response to those challenges, providing prescribers with a trusted, quality-assured formulation from a pharmacy they can count on. The launch of GS-441524 builds on Wedgewood's long-standing role in supporting veterinarians with customized treatment solutions for complex cases. As part of its commitment to responsible compounding, the pharmacy emphasizes that its GS-441524 formulation is not approved by the FDA, has not been studied in clinical trials, and Wedgewood makes no claims of efficacy or safety. Independent third-party studies related to GS-441524 are available for veterinary reference through Wedgewood's FIP Resource Center. To learn more about GS-441524 and access educational resources, visit About Wedgewood Wedgewood is the nation's largest and most trusted provider of compounded veterinary medications. Its next-generation home delivery platform, Blue Rabbit, streamlines patient care and marks a significant evolution in online pharmacy services. Together, Blue Rabbit and Wedgewood serve more than 70,000 veterinary professionals and more than one million animals annually. For more information visit About FIP Global Cats FIP Global CATS® (Community, Advocacy, Treatment, Support) is a leading organization in the fight against feline infectious peritonitis (FIP). Uniting veterinarians, researchers, and pet owners, it provides crucial support to those facing an FIP diagnosis. The organization is committed to empowering pet parents, advocating for safe, effective and affordable legal treatments, and advancing FIP research. For more information, please visit
Associated Press
5 days ago
- General
- Associated Press
Austin Varghese & Famas Shanavas: First Indians in FIP Bronze Main Draw
A New Chapter in Indian Padel History: Austin Varghese and Famas Shanavas Become First Indian Pair to Qualify Directly for FIP Bronze Main Draw JAKARTA, INDONESIA, June 3, 2025 / / -- Indian padel athletes Austin Varghese and Famas Shanavas have made history by becoming the first Indian team to directly qualify for the main draw of a FIP Bronze tournament, marking a groundbreaking achievement in the sport's development within India. The International Padel Federation (FIP), the official governing body for padel worldwide, oversees the sport's global tournament structure, which includes Bronze, Silver, and Gold events. These tournaments offer ranking points essential for climbing the international leaderboard and are officially recognized by the International Olympic Committee (IOC). From Local Champions to Global Contenders Austin and Famas began their journey in 2021 and quickly rose through the national ranks, becoming Kerala's first-ever padel champions in 2024. That same year, they represented India at the nation's inaugural FIP tournament held in Delhi. In January 2025, the duo was ranked outside the top 1000. As of May, they have surged into the top 600 in the world, with eyes set on breaking into the top 500 by mid-year and reaching the top 400 by the end of 2025. Representing a Mission Beyond the Court Padel is one of the fastest-growing racket sports in the world, and for players looking to compete at an international level, FIP tournaments are a crucial stepping stone. 'This is not just a personal battle,' Austin and Famas said in a joint statement. 'It's our effort to inspire a new generation of Indian padel players. With the right support, we believe we can lead the growth of padel in India.' Their plan for the coming years includes representing India in 10 international FIP tournaments in 2025 and 15 in 2026, aiming to become the highest-ranked Indian padel team globally. A Milestone for Indian Sport This historic qualification marks a turning point for Indian padel on the global stage. As the sport gains momentum, Austin Varghese and Famas Shanavas are setting a benchmark for future Indian athletes to follow. Austin Varghese Padel Coaches Dubai +971 56 947 1699 [email protected] Visit us on social media: Instagram Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Indian Express
28-05-2025
- Politics
- Indian Express
Scan databases before giving IDs: Govt to states on illegal Bangladeshis, Rohingya crackdown
Intensifying its crackdown on foreigners staying illegally in India, the Ministry of Home Affairs has asked states, Union Territories and authorities which issue Aadhaar, voter ID and ration cards to check if the applicant's name figures in a database of immigrants before issuing any document to them, The Indian Express has learnt. The move is the latest in a series of steps to crack down on illegal immigration, ensure that those here illegally are deported at the earliest, and make sure they are not able to get access to documents or ID proofs that Indians are entitled to. As reported by The Indian Express earlier this month, the MHA has also set a 30-day deadline for states and Union Territories to verify the credentials of persons suspected to be illegal immigrants from Bangladesh and Myanmar who claim to be Indian citizens. After the 30-day period, if their documents are not verified, they will face deportation, it is learnt. According to officials, states, UTs and relevant authorities will be provided access to an integrated server containing databases of the Immigration Visa Foreigner Registration Tracking (IVFRT) system, the Foreigners Identification Portal (FIP), and the Indo-Myanmar Border (IMB) pass system. In a communication earlier this month, the Ministry wrote, 'Recently, several reports/concerns have been raised to the MHA regarding procurement of Indian documents — voter ID card, Aadhaar card, Ayushman card, Indian passport and ration card — by foreigners through fraudulent means, bypassing the procedure made by the law for claiming benefits and facilities which they are not entitled to. This is a serious matter, and it also leads to illegal/criminal and anti-national activities by such foreigners using fake IDs.' A senior official from the paramilitary forces said the 'database, including biometrics of foreigners entering India from the Indo-Myanmar border, is available in the IMB pass system, and the MHA is in the process of integrating it with the IVFRT. Eventually, all three databases will be made available to Indian authorities issuing identity/beneficiary documents through a common integration server.' Emphasising the need to incorporate this step before issuing any documents, the MHA wrote, 'With a view to prevent foreigners from procuring Indian documents and claiming social benefits which are exclusively reserved for Indian citizens, authorities in the State government and UT administration issuing any such Indian document or providing social benefit to Indian citizens should mandatorily cross check the details of applicant with the database available in the IVFRT, FIP and IMB border pass systems through the common integration server, to ensure that the applicant is not a foreign national.' The MHA also directed that details of those who have already been granted Indian documents/social benefits be cross-checked with the three databases. 'During such checking, if any match is found, the Indian document or social benefits provided to the particular individual need to be deactivated or cancelled forthwith as per established due process,' it wrote. 'Details of such individuals, whose Indian documents issued or the social benefits provided have been deactivated/cancelled, should also be shared with other concerned agencies for deactivation/cancellation of documents issued by them,' the MHA wrote. In February, Union Home Minister Amit Shah had said that strict action should be taken against any network that helps illegal Bangladeshi and Rohingya immigrants enter the country, obtain documents, and facilitate their stay. 'The issue of illegal intruders is also related to national security, and it should be dealt with strictly. They should be deported,' Shah had said. Mahender Singh Manral is an Assistant Editor with the national bureau of The Indian Express. He is known for his impactful and breaking stories. He covers the Ministry of Home Affairs, Investigative Agencies, National Investigative Agency, Central Bureau of Investigation, Law Enforcement Agencies, Paramilitary Forces, and internal security. Prior to this, Manral had extensively reported on city-based crime stories along with that he also covered the anti-corruption branch of the Delhi government for a decade. He is known for his knack for News and a detailed understanding of stories. He also worked with Mail Today as a senior correspondent for eleven months. He has also worked with The Pioneer for two years where he was exclusively covering crime beat. During his initial days of the career he also worked with The Statesman newspaper in the national capital, where he was entrusted with beats like crime, education, and the Delhi Jal Board. A graduate in Mass Communication, Manral is always in search of stories that impact lives. ... Read More
Business Insider
17-05-2025
- Business
- Business Insider
FTAI Infrastructure files to sell 22.24M shares of common stock for holders
17:25 EDT FTAI Infrastructure (FIP) files to sell 22.24M shares of common stock for holders Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
